<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Parexel International Corp.</title>
	<atom:link href="http://www.stockbloghub.com/tag/parexel-international-corp/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(PRXL) PAREXEL International Corporation &#8211; Value &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/04/02/prxl-parexel-international-corporation-value-zacks-rank-buy/5021</link>
		<comments>http://www.stockbloghub.com/2009/04/02/prxl-parexel-international-corporation-value-zacks-rank-buy/5021#comments</comments>
		<pubDate>Thu, 02 Apr 2009 19:25:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Research Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[Parexel International Corp.]]></category>
		<category><![CDATA[PRXL]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=5021</guid>
		<description><![CDATA[PAREXEL International Corporation (PRXL), which provides consulting services to the drug and medical device industries, reported record service revenue that climbed 15.6% in its fiscal second quarter. The company has surprised on estimates 4 consecutive quarters by an average of 9.08%. PRXL has a PEG ratio of 0.60. Company Description PAREXEL International provides contract research and consulting services to the pharmaceutical, biotech and medical device industries in 51 countries around the world. The company&#8217;s services include helping clients bring new drugs to market through all phases of drug development and commercialization Incorporatedluding regulatory consulting and clinical trials. Service Revenue Hits Record in the Second Quarter 2009 PAREXEL reported second quarter fiscal 2009 results on Jan 26 and beat Wall Street estimates by 15%. Excluding a charge for a contract termination ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/04/02/prxl-parexel-international-corporation-value-zacks-rank-buy/5021/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

